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Respiratory complex III (CIII) is the central complex of the respiratory
chain. In its native form, CIII is dimeric, and is closely associated in varying
proportions with CI and CIV to form supramolecular structures, called
supercomplexes [1]. The occurrence of such supercomplexes as structural
and functional entities has been recently documented [1,2]. However, the
physiological implications of such speciﬁc supramolecular interactions
are not yet fully understood. Mutations in cytochrome b, which is the
only CIII subunit encoded by the mitochondrial genome, are among
the least common abnormalities identiﬁed to date in humans [3].
Recent studies on the bacterial enzyme proposed that speciﬁc amino
acids at the Qo site of CIII might provide protective mechanisms
against oxidative damage. Interestingly, the conserved Tyr residue at
position 302 of Rhodobacter capsulatus cytochrome b is critical for this
process [4]. The same mutation at position 278 of human cytochrome
b (p.Y278C, m.15579ANG) has also been encountered in a patient
with severe exercise intolerance and multisystem disorder [5]. Here
we have utilized cybrids bearing the homoplasmic p.Y278C mutation
to dissect the biochemical alterations in CIII activity, ROS production
and supercomplexes assembly/stability. Despite a dramatic reduction
in CIII activity, and in CIII-driven ATP synthesis, the CI and I+III
activities were less affected, and the rate of ATP synthesis driven by CI
or CII substrates was only partially reduced. Accordingly, mutated
cybrids maintained the mitochondrial potential in the presence of
oligomycin. Remarkably, the p.Y278C mutation enhanced superoxide
production and perturbed glutathione homeostasis. Finally, exami-
nation of respiratory supercomplexes revealed that dimeric CIII and
III2IV1 were markedly decreased, whereas supercomplexes I1III2IVn
increased. These ﬁndings suggest that the deleterious effects of
cytochrome b p.Y278C mutation are mitigated when CIII is assembled
into the supercomplexes I1III2IVn and underline the importance of
supramolecular interactions between respiratory complexes on dis-
ease manifestations associated with this mutation.
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Both respiratory and photosynthetic electron transport are crucial
for energy conversion in plants and many microbes. In cyanobacteria,
respiratory electron transport takes place in close proximity to pho-
tosynthetic electron transport, because the complexes required for both
processes are locatedwithin the thylakoidmembranes [1,2]. This allows
“unorthodox” electron transport pathways in which electrons cross
over from respiratory donors to photosynthetic acceptors, or vice versa
[3]. The balance of electron transport routes is crucial for cell physiology
[4], yet the factors that control the predominance of particular path-
ways are poorly understood. Herewe use a combination of taggingwith
green ﬂuorescent protein and confocal ﬂuorescence microscopy in live
cells of the cyanobacterium Synechococcus elongatus PCC 7942 to
investigate the distribution on submicron scales of two key respira-
tory electron donors, type-I NAD(P)H dehydrogenase (NDH-1) and
succinate dehydrogenase (SDH) [5]. When cells are grown under low
light, both complexes are concentrated in discrete patches in the
thylakoid membranes, about 100–300 nm in diameter and containing
tens to hundreds of complexes. Exposure to moderate light leads to
redistribution of both NDH-1 and SDH such that they become evenly
distributed within the thylakoid membranes. The effects of electron
transport inhibitors indicate that redistribution of respiratory com-
plexes is triggered by changes in the redox state of an electron carrier
close to plastoquinone. Redistribution does not depend on de novo
protein synthesis, and it is accompanied by a major increase in the
probability that respiratory electrons are transferred to photosystem I
rather than to a terminal oxidase. These results indicate that the
distribution of complexes on the scale of 100–300 nm controls the
partitioning of reducing power and that redistribution of electron
transport complexes on these scales is a physiological mechanism to
regulate the pathways of electron ﬂow.
References
[1] W.F. Vermaas, In: Encyclopedia of Life Sciences, Nature Publish-
ing Group, London, 2001, pp. 245–251.
[2] G.A. Peschek, C. Obinger, M. Paumann, Physiol. Plant. 120 (2004)
358–369.
[3] A.R. Grossman, K.R.M. Mackey, S. Bailey, J. Phycol. 46 (2010)
629–634.
[4] A.H. Millar, J. Whelan, K.L. Soole, D.A. Day, Annu. Rev. Plant Biol.
62 (2011) 79–104.
[5] L.-N. Liu, S.J. Bryan, F. Huang, J. Yu, P.J. Nixon, P.R. Rich, C.W.
Mullineaux, Proc. Natl. Acad. Sci. U. S. A. (in press).
doi:10.1016/j.bbabio.2012.06.366
18P4
Identiﬁcation of potential biomarkers for complex III deﬁciency
by 2D-DIGE proteomic approach
L. Marin-Buera, M. Martínez Gomáriz, C. Ugalde
Instituto de Investigación del Hospital Universitario 12 de Octubre,
Avenida Córdoba s/n 28041 Madrid, Spain
Unidad de Proteómica de la Universidad Complutense de Madrid,
Facultad de Farmacia-UCM Plaza Ramón y Cajal s/n 28040, Madrid, Spain
E-mail: lmarin@h12o.es
Mitochondrial complex III deﬁciency is a relatively infrequent
disorder that underlies a wide range of neuromuscular and multi-
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